Potent Antipneumococcal Activity of Gemifloxacin Is Associated with Dual Targeting of Gyrase and Topoisomerase IV, an In Vivo Target Preference for Gyrase, and Enhanced Stabilization of Cleavable Complexes In Vitro

We investigated the roles of DNA gyrase and topoisomerase IV in determining the susceptibility of Streptococcus pneumoniae to gemifloxacin, a novel fluoroquinolone which is under development as an antipneumococcal drug. Gemifloxacin displayed potent activity against S. pneumoniae 7785 (MIC, 0.06 μg/...

Full beskrivning

Bibliografiska uppgifter

I publikationen:	Antimicrob Agents Chemother
Huvudupphov:	Heaton, Victoria J., Ambler, Jane E., Fisher, L. Mark
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	American Society for Microbiology (ASM) 2000
Ämnen:	Mechanisms of Action: Physiological Effects
Länkar:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC101612/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11036032/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.11.3112-3117.2000
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!